Lawrence C. Greed

Nedlands, WA, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 14 publications

A seven-year review of the RCPAQAP dried bloodspot external quality assurance program.

A seven-year review of the RCPAQAP dried bloodspot external quality assurance program.

Journal: Clinical chemistry and laboratory medicine
Published: March 26, 2026

A Survey of Current Australasian Practices in the Use of Residual Bloodspots for the Addition of a New Disorder to the Screening Panel.

A Survey of Current Australasian Practices in the Use of Residual Bloodspots for the Addition of a New Disorder to the Screening Panel.

Journal: International journal of neonatal screening
Published: January 30, 2026

Evidence-based multidisciplinary model of care for newborn screening in spinal muscular atrophy.

Evidence-based multidisciplinary model of care for newborn screening in spinal muscular atrophy.

Journal: Genetics in medicine : official journal of the American College of Medical Genetics
Published: August 13, 2025

Australasian guideline for the performance of sweat chloride testing 3rd edition: to support cystic fibrosis screening, diagnosis and monitoring.

Australasian guideline for the performance of sweat chloride testing 3rd edition: to support cystic fibrosis screening, diagnosis and monitoring.

Journal: Clinical chemistry and laboratory medicine
Published: April 07, 2025

Is sweat conductivity still a relevant screening test for cystic fibrosis? Participation over 10 years.

Is sweat conductivity still a relevant screening test for cystic fibrosis? Participation over 10 years.

Journal: Clinical chemistry and laboratory medicine
Published: August 07, 2024

Counting Conditions on Newborn Bloodspot Screening Panels in Australia and New Zealand.

Counting Conditions on Newborn Bloodspot Screening Panels in Australia and New Zealand.

Journal: International journal of neonatal screening
Published: April 19, 2024

Fifty years of newborn screening for congenital hypothyroidism: current status in Australasia and the case for harmonisation.

Fifty years of newborn screening for congenital hypothyroidism: current status in Australasia and the case for harmonisation.

Journal: Clinical chemistry and laboratory medicine
Published: April 24, 2022

A novel variant in COX16 causes cytochrome c oxidase deficiency, severe fatal neonatal lactic acidosis, encephalopathy, cardiomyopathy, and liver dysfunction.

A novel variant in COX16 causes cytochrome c oxidase deficiency, severe fatal neonatal lactic acidosis, encephalopathy, cardiomyopathy, and liver dysfunction.

Journal: Human mutation
Published: July 16, 2020

Beneficial outcome of early dietary lysine restriction as an adjunct to pyridoxine therapy in a child with pyridoxine dependant epilepsy due to Antiquitin deficiency.

Beneficial outcome of early dietary lysine restriction as an adjunct to pyridoxine therapy in a child with pyridoxine dependant epilepsy due to Antiquitin deficiency.

Journal: JIMD reports
Published: July 11, 2019

Ketogenic diet, a potentially valuable therapeutic option for the management of refractory epilepsy in classical neonatal nonketotic hyperglycinemia: a case report.

Ketogenic diet, a potentially valuable therapeutic option for the management of refractory epilepsy in classical neonatal nonketotic hyperglycinemia: a case report.

Journal: European journal of clinical nutrition
Published: March 03, 2018

Metabolite diagnosis of primary hyperoxaluria type 3.

Metabolite diagnosis of primary hyperoxaluria type 3.

Journal: Pediatric nephrology (Berlin, Germany)
Published: March 26, 2017

Heterozygous Monocarboxylate Transporter 1 (MCT1, SLC16A1) Deficiency as a Cause of Recurrent Ketoacidosis.

Heterozygous Monocarboxylate Transporter 1 (MCT1, SLC16A1) Deficiency as a Cause of Recurrent Ketoacidosis.

Journal: JIMD reports
Published: August 04, 2015
Showing 1-12 of 14

Last Updated: 09/26/2026